Secondary invasive interventions · intermittent claudication
Endovascular revascularisation plus conservative therapy leads to lower secondary invasive interventions compared with conservative therapy alone (high certainty).
1 finding from 1 review
Disease‐specific quality of life · intermittent claudication
1 finding from 1 review
Pain‐free walking distance · intermittent claudication
2 findings from 1 review
Secondary invasive interventions · intermittent claudication
Endovascular revascularisation showed no clear difference in secondary invasive interventions compared with no specific therapy (moderate certainty).
1 finding from 1 review
Disease‐specific quality of life · intermittent claudication
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Maximum walking distance · intermittent claudication
2 findings from 1 review
Intervention not reported
Pain‐free walking distance (m) · adults with intermittent claudication
1 finding from 1 review
Intervention not reported
Maximum walking distance (m) · adults with intermittent claudication
1 finding from 1 review
Intervention not reported
Ankle brachial index · adults with intermittent claudication
1 finding from 1 review
Intervention not reported
Mortality: all‐cause deaths · adults with intermittent claudication
The intervention showed no clear difference in mortality: all‐cause deaths (moderate certainty).
1 finding from 1 review
Intervention not reported
Amputation · adults with intermittent claudication
The intervention showed no clear difference in amputation (low certainty).
1 finding from 1 review
Intervention not reported
Quality of Life SF‐36 Physical Summary score (scale 0 to 100, higher score indicates better quality of life) · adults with intermittent claudication
1 finding from 1 review
Intervention not reported
Quality of Life SF‐36 Mental Summary score (scale 0 to 100, higher score indicates better quality of life) · adults with intermittent claudication
1 finding from 1 review
Pain‐free walking distance · people with symptomatic intermittent claudication
1 finding from 1 review
Change in maximum walking distance (MWD) · people with symptomatic intermittent claudication
1 finding from 1 review
Final value MWD · people with symptomatic intermittent claudication
1 finding from 1 review
Adverse effects · people with symptomatic intermittent claudication
It is very uncertain whether padma 28 changes adverse effects compared with placebo (very low certainty).
1 finding from 1 review
Ankle brachial index · people with symptomatic intermittent claudication
1 finding from 1 review
ABI ‐ change from baseline · people with symptomatic intermittent claudication
1 finding from 1 review
Incidence of PEa (early postoperative period) · people undergoing surgery or at risk of developing VTE because of surgery, trauma or ICU stay
IPC plus pharmacological prophylaxis may leads to lower incidence of PEa (early postoperative period) compared with IPC alone (low certainty).
1 finding from 1 review